Nektar Therapeutics company logo
Nektar Therapeutics logo

Nektar Therapeutics (NKTR) EBITDA

Annual EBITDA

-$133.45M$4.72M-3.67%

Summary

Current Value
As of today, NKTR annual EBITDA is -$133.45M, down -3.67% on
Historical Performance
NKTR annual EBITDA is up +41.48% over the past 3 years, up +63.68% over the past 5 years
All-Time High Comparison
NKTR annual EBITDA is currently -119.15% below its historical high of $696.73M set on
3-Year Low Comparison
NKTR annual EBITDA is +41.48% above its 3-year low of -$228.04M reached on an earlier date
Sector Comparison
NKTR annual EBITDA is higher than 12.91% of companies in Healthcare sector

EBITDA Chart

SUGGESTED SERIES

Performance

NKTR Performance
MetricDateValue1Y3Y5Y15Y
-$133.45M-3.7%+41.5%+63.7%-10000.0%
-$18.90M+22.4%+51.0%+82.4%-383.3%
-$129.75M-3.4%+43.1%+64.5%-10000.0%
Price$83.37+811.1%+577.8%-72.3%-44.8%
-
$55.23M-43.9%-40.0%-63.9%-65.3%
-$9.73-12.1%-394.3%-290.8%-2331.3%
-$130.77M+1.8%+45.6%+65.6%-734.0%
-$164.08M-37.9%+55.4%+63.1%-332.5%

EBITDA Highs

NKTR Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y-$128.73M-3.7%
5Y-$128.73M-3.7%
All$696.73M-119.2%

EBITDA Lows

NKTR Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$228.04MN/A+41.5%
5Y-$433.10M+69.2%
All-$433.10M+69.2%

EBITDA History

YearValueChange
-$133.45M-3.7%
-$128.73M+0.7%
-$129.61M+43.2%
-$228.04M+47.3%
-$433.10M-17.9%
-$367.42M+14.4%
-$429.04M-161.6%
$696.73M+2,743.0%
-$26.36M+73.5%
-$99.66M-565.7%
-$14.97M-212.9%
-$4.79M+95.0%
-$95.83M+23.8%
-$125.73M-18.3%
-$106.24M>-9,900.0%
$872.00K+101.1%
YearValueChange
-$80.25M+34.9%
-$123.30M-157.2%
-$47.94M+51.4%
-$98.60M-15.5%
-$85.34M-52.6%
-$55.93M-16.6%
-$47.97M+39.3%
-$79.06M-9.0%
-$72.57M-32.9%
-$54.59M-130.3%
-$23.71M-27.6%
-$18.58M-63.1%
-$11.39M-9.3%
-$10.42M-32.3%
-$7.87M-51.1%
-$5.21M-

FAQ

  • What is the current annual EBITDA of NKTR?

    As of today, NKTR annual EBITDA is -$133.45M

  • What is 1-year change in NKTR annual EBITDA?

    NKTR annual EBITDA is down -3.67% year-over-year

  • What is 3-year change in NKTR annual EBITDA?

    NKTR annual EBITDA is up +41.48% over the past 3 years

  • How far is NKTR annual EBITDA from its all-time high?

    NKTR annual EBITDA is currently -119.15% below its historical high of $696.73M set on December 31, 2018

  • How does NKTR annual EBITDA rank versus sector peers?

    NKTR annual EBITDA is higher than 12.91% of companies in Healthcare sector

  • When is NKTR next annual earnings release?

    As of today, the next annual earnings release for NKTR has not been scheduled

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. NKTR Official Website www.nektar.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/906709/000119312526104547/0001193125-26-104547-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/906709/000119312526104547/0001193125-26-104547-index.htm
  4. NKTR Profile on Yahoo Finance finance.yahoo.com/quote/NKTR
  5. NKTR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nktr